Exploratory/Developmental Clinical Research Grants in Obesity (R21 Clinical Trial Optional)

Funding Agency:
National Institutes of Health

 This Funding Opportunity Announcement (FOA) encourages research grant applications from institutions/organizations that propose to conduct exploratory/developmental clinical studies that will accelerate the development of effective interventions for prevention or treatment of overweight or obesity in adults and/or children.  Exploratory epidemiological research with a goal of informing translational/clinical research will also be supported within this program.

Deadlines:

  • R21 Deadlines: Feb. 16, Jun. 16, Oct. 16.
  • AIDS Deadlines: Jan. 7, May 7, Sep. 7

PA-18-720 Expiration Date: May 8, 2021

Agency Website

Amount

$275,000

Amount Description

Direct costs are limited to $275,000 over an R21 two-year period, with no more than $200,000 in direct costs allowed in any single year.

Funding Type

Grant

Eligibility

Faculty

Category

Medical
Medical - Clinical Science
Medical - Translational

External Deadline

October 16, 2019